Skip to content

ResMed RMD Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Pulmonx Corporation logo
Pulmonx CorporationLUNG
10M0.0%

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$28.27B-19.1%
Enterprise value$27.71B-19.8%
P/E18.6×-6.3×
P/S5.1×-1.7×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp
FCF margin31.7%+0.4pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's convertible preferred stock authorized shares?
ResMed (RMD) reported convertible preferred stock authorized shares of 2M in Q1 2026.
How has ResMed's convertible preferred stock authorized shares changed year-over-year?
ResMed's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 2M to 2M.
What is the long-term trend for ResMed's convertible preferred stock authorized shares?
Over 4 years (2021 to 2025), ResMed's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 2M to 2M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.